Literature DB >> 10700180

Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.

K E Nichols1, J D Crispino, M Poncz, J G White, S H Orkin, J M Maris, M J Weiss.   

Abstract

Haematopoietic development is regulated by nuclear protein complexes that coordinate lineage-specific patterns of gene expression. Targeted mutagenesis in embryonic stem cells and mice has revealed roles for the X-linked gene Gata1 in erythrocyte and megakaryocyte differentiation. GATA-1 is the founding member of a family of DNA-binding proteins that recognize the motif WGATAR through a conserved multifunctional domain consisting of two C4-type zinc fingers. Here we describe a family with X-linked dyserythropoietic anaemia and thrombocytopenia due to a substitution of methionine for valine at amino acid 205 of GATA-1. This highly conserved valine is necessary for interaction of the amino-terminal zinc finger of GATA-1 with its essential cofactor, FOG-1 (for friend of GATA-1; refs 9-12). We show that the V205M mutation abrogates the interaction between Gata-1 and Fog-1, inhibiting the ability of Gata-1 to rescue erythroid differentiation in an erythroid cell line deficient for Gata-1 (G1E). Our findings underscore the importance of FOG-1:Gata-1 associations in both megakaryocyte and erythroid development, and suggest that other X-linked anaemias or thrombocytopenias may be caused by defects in GATA1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700180     DOI: 10.1038/73480

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  162 in total

1.  Distinct domains of the GATA-1 cofactor FOG-1 differentially influence erythroid versus megakaryocytic maturation.

Authors:  Alan B Cantor; Samuel G Katz; Stuart H Orkin
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.

Authors:  Ulrich Dührsen; Christian P Kratz; Christian Flotho; Thomas Lauenstein; Martin Bommer; Erika König; Günter Brittinger; Hermann Heimpel
Journal:  Ann Hematol       Date:  2010-10-05       Impact factor: 3.673

Review 3.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

4.  Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors.

Authors:  Xun Wang; John D Crispino; Danielle L Letting; Minako Nakazawa; Mortimer Poncz; Gerd A Blobel
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

5.  Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2.

Authors:  Eduardo Anguita; Jim Hughes; Clare Heyworth; Gerd A Blobel; William G Wood; Douglas R Higgs
Journal:  EMBO J       Date:  2004-06-24       Impact factor: 11.598

6.  Cofactor-mediated restriction of GATA-1 chromatin occupancy coordinates lineage-specific gene expression.

Authors:  Timothy M Chlon; Louis C Doré; John D Crispino
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

Review 7.  GATA transcription factors in hematologic disease.

Authors:  Alan B Cantor
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

8.  Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1.

Authors:  Stephan Kadauke; Maheshi I Udugama; Jan M Pawlicki; Jordan C Achtman; Deepti P Jain; Yong Cheng; Ross C Hardison; Gerd A Blobel
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

9.  GATA-1-mediated proliferation arrest during erythroid maturation.

Authors:  Marcin Rylski; John J Welch; Ying-Yu Chen; Danielle L Letting; J Alan Diehl; Lewis A Chodosh; Gerd A Blobel; Mitchell J Weiss
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  FOG-1-mediated recruitment of NuRD is required for cell lineage re-enforcement during haematopoiesis.

Authors:  Zhiguang Gao; Zan Huang; Harold E Olivey; Sandeep Gurbuxani; John D Crispino; Eric C Svensson
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.